Recent Advances in Drug Delivery for Cancer Therapy
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 15 July 2024 | Viewed by 183
Special Issue Editors
Interests: renal cancer; lung cancer; drug resistance; drug delivery systems; liposomes; nanomaterials; nanomedicine; xenograft models
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are pleased to announce a Special Issue focused on the diverse and dynamic field of drug delivery research, with a particular emphasis on its significant role in advancing cancer treatment. The development of novel materials or carrier systems for effective therapeutic drug delivery has revolutionized cancer therapy, allowing for targeted approaches that minimize side effects and maximize therapeutic efficacy.
This Special Issue aims to showcase recent breakthroughs and cutting-edge strategies in drug delivery for cancer therapy. We believe that this theme will inspire engaging discussions and foster collaboration among researchers in the field.
We eagerly anticipate receiving your valuable contributions to this Special Issue. Your expertise and insights will undoubtedly enrich the content and impact of this publication.
Thank you for considering this invitation, and we look forward to your participation.
Dr. Krishnendu Pal
Dr. Geeta Rao
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- drug delivery
- cancer therapy
- nanomedicine
- chemotherapy
- cancer treatment
